Chugai Pharmaceutical Co., Ltd. (CHGCY)
19.28
-0.03
(-0.16%)
USD |
OTCM |
Oct 06, 16:00
Chugai Pharmaceutical Profit Margin (Quarterly) : 34.06% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.06% |
| March 31, 2026 | 35.87% |
| December 31, 2025 | 37.08% |
| September 30, 2025 | 33.38% |
| June 30, 2025 | 33.50% |
| March 31, 2025 | 33.71% |
| December 31, 2024 | 30.31% |
| September 30, 2024 | 34.69% |
| June 30, 2024 | 35.41% |
| March 31, 2024 | 31.40% |
| December 31, 2023 | 33.31% |
| September 30, 2023 | 30.08% |
| June 30, 2023 | 31.11% |
| March 31, 2023 | 23.54% |
| December 31, 2022 | 23.37% |
| September 30, 2022 | 30.09% |
| June 30, 2022 | 30.72% |
| March 31, 2022 | 49.05% |
| December 31, 2021 | 30.67% |
| September 30, 2021 | 29.94% |
| June 30, 2021 | 31.94% |
| March 31, 2021 | 28.08% |
| December 31, 2020 | 24.86% |
| September 30, 2020 | 28.85% |
| June 30, 2020 | 26.90% |
| Date | Value |
|---|---|
| March 31, 2020 | 28.72% |
| December 31, 2019 | 22.65% |
| September 30, 2019 | 25.53% |
| June 30, 2019 | 20.62% |
| March 31, 2019 | 22.70% |
| December 31, 2018 | 14.48% |
| September 30, 2018 | 15.44% |
| June 30, 2018 | 15.17% |
| March 31, 2018 | 19.10% |
| December 31, 2017 | 10.71% |
| September 30, 2017 | 15.81% |
| June 30, 2017 | 13.99% |
| March 31, 2017 | 14.92% |
| December 31, 2016 | 8.19% |
| September 30, 2016 | 10.25% |
| June 30, 2016 | 13.57% |
| March 31, 2016 | 12.26% |
| December 31, 2015 | 10.53% |
| September 30, 2015 | 13.94% |
| June 30, 2015 | 12.98% |
| March 31, 2015 | 12.66% |
| December 31, 2014 | 9.01% |
| September 30, 2014 | 10.01% |
| June 30, 2014 | 10.56% |
| March 31, 2014 | 15.38% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Eisai Co., Ltd. | 8.17% |
| Santen Pharmaceutical Co., Ltd. | 10.44% |
| Ono Pharmaceutical Co., Ltd. | 20.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.88% |
| Return on Assets | 20.19% |
| Return on Invested Capital | 23.67% |
| Gross Profit Margin (Quarterly) | 69.49% |
| Operating Margin (Quarterly) | 48.47% |
| Return on Net Operating Assets | 40.94% |